The study, titled “Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic Fibrosis,” analyzed imaging and clinical data from 106 individuals with CF who were imaged and ...

Peak nasal inspiratory flow (PNIF) measurement was a feasible, noninvasive method for assessing nasal airflow obstruction in children with cystic fibrosis and correlated significantly with nasal ...

Cystic fibrosis (CF) and pulmonary fibrosis (PF) are two chronic conditions that damage the lungs. Treatment for both aims to improve breathing, manage symptoms, and prevent further lung damage. Your ...

Please provide your email address to receive an email when new articles are posted on . Percent predicted FEV 1 did not improve after systemic corticosteroid treatment. This treatment was also not ...

Please provide your email address to receive an email when new articles are posted on . Gaps in cystic fibrosis care negatively impacted lung function. Between continuous and discontinuous care, the ...

Monthly administration of liposome-delivered gene therapy for cystic fibrosis (CF) improved forced expiratory volume (FEV) in a randomized, double-blinded, placebo-controlled phase 2b clinical trial.

Mar. 23 -- FRIDAY, Nov. 30 (HealthDay News) -- The common pain reliever and anti-inflammatory ibuprofen significantly slows the decline in lung function seen in children with cystic fibrosis, U.S.

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

Cystic fibrosis is caused by genetic changes and is always present at birth. Although rare, cystic fibrosis isn’t diagnosed in some people who have mild symptoms until they’re adults. This is known as ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to deliver genetic therapies straight to lung cells. This innovation could transform ...

The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...